Block Inc. stock drop of 20% reflects fintech struggles, driven by weak Q1 earnings, stagnant Cash App growth, and reduced full-year guidance.
Discover top European dividend stocks to watch in 2025, including undervalued gems offering high yields and stability for income-focused investors.
Equity analysis in 2025 is vital for navigating sector-specific challenges, leveraging AI, and identifying growth opportunities in a volatile financial landscape.
Discover how the coverage-gap score reveals companies with few equity analysts vs market cap, highlighting risks, opportunities, and undervalued stocks in 2025.
AI's energy hunger reshapes equity analysis in the energy sector, straining resources, increasing emissions, and challenging sustainability goals globally.
Discover the 5 top pharma stocks to watch in 2025. Gain equity analysis insights on Eli Lilly, J&J, Merck, Thermo-Fisher, and AbbVie for strong growth.
J&J reports durability data for bladder cancer 'pretzel' drug TAR-200, showing a 72.7% complete response rate and sustained benefits after FDA filing.
The rise of green energy: how renewable energy is transforming the tech industry in 2025 through AI, data centers, and innovative energy solutions.
Green Pharma is revolutionizing the pharmaceutical industry by using renewable energy to cut emissions, reduce waste, and promote sustainable drug manufacturing.
Analysts discuss Chipotle's Q1 2025 financial performance, highlighting growth strategies, economic challenges, and its potential for long-term success.